Hideki Ohdan

Last Updated :2017/11/06

Affiliations, Positions
Graduate School of Biomedical & Health Sciences (Biomedical Sciences Major), Professor
Web Site
E-mail
hohdanhiroshima-u.ac.jp
Other Contact Details
"1-2-3 KASUMI, MINAMI-KU, HIROSHIMA 734-8551", Japan
TEL : (+81)82-257-5220 FAX : (+81)82-257-5224

Basic Information

Major Professional Backgrounds

  • 2003/04/01, 2003/09/30, Hiroshima University, Hospital, Research Associate
  • 2003/10/01, 2004/03/31, Hiroshima University, Hospital, Research Associate
  • 2004/04/01, 2007/03/31, Hiroshima University, Hospital, Research Associate
  • 2007/04/01, 2008/03/31, Hiroshima University, Department of Surgery, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Associate Professor
  • 2008/04/01, Hiroshima University, Department of Surgery, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Professor
  • 2012/04/01, Hiroshima University, Department of Gastroenterological and Transplant Surgery, Applied Life Sciences, Professor

Educational Backgrounds

  • Hiroshima University, Faculty of Medicine, Japan, 1982/04, 1988/03
  • Hiroshima University, Graduate School, Division of Medical Sciences, Programs for Surgery, Japan, 1993/04, 1997/03

Academic Degrees

  • Ph.D. , M.D., Hiroshima University

Educational Activity

  • School of Medicine:Program of Medicine, Graduate School of Biomedical & Health Sciences:Biomedical Sciences Major

In Charge of Primary Major Programs

  • Dentistry
  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;General surgery

Research Keywords

  • gastroenterological Surgery
  • organ transplantation
  • immunology

Affiliated Academic Societies

  • Japanese Surgical Society
  • the Japan Soceity for Transplantation
  • The Japanese Society of Gastroenterological Surgery
  • Japanese Liver Transplantation Soceity
  • Japanese Society of Hepato-Biliary-Pancreatic Surgery
  • The Japan Society of Hepatology
  • The Japan Society for Organ Preservation and Biology
  • Japanese Soceity for Clinical Renal Transplantation
  • The Japanese Soceity of Gastroenterology
  • Japan Organ Transplant Network
  • Hiroshima Donor Bank
  • Japan Soceity of Computer Aided Surgery
  • The Transplantation Society

Educational Activity

Course in Charge

  1. 2017, Liberal Arts Education Program1, 4Term, Social medicine and disease control
  2. 2017, Undergraduate Education, Intensive, Clinical diagnosis and treatment I
  3. 2017, Undergraduate Education, Intensive, Practice for medical research
  4. 2017, Undergraduate Education, Intensive
  5. 2017, Undergraduate Education, Intensive, Clinical Clerkship (Advanced Course)
  6. 2017, Undergraduate Education, First Semester, Surgery I
  7. 2017, Graduate Education (Doctoral Program) , Second Semester, Creation and Development of Biomedical Sciences
  8. 2017, Graduate Education (Doctoral Program) , Second Semester, Creation and Development of Biomedical Sciences
  9. 2017, Graduate Education (Doctoral Program) , Second Semester, Creation and Development of Biomedical Sciences
  10. 2017, Graduate Education (Master's Program) , Second Semester, General clinical medicine and dentistry
  11. 2017, Graduate Education (Doctoral Program) , First Semester, Advanced seminar on Gastroenterological and Transplant Surgery
  12. 2017, Graduate Education (Doctoral Program) , Second Semester, Advanced seminar on Gastroenterological and Transplant Surgery
  13. 2017, Graduate Education (Doctoral Program) , First Semester, Advanced research on Gastroenterological and Transplant Surgery
  14. 2017, Graduate Education (Doctoral Program) , Second Semester, Advanced research on Gastroenterological and Transplant Surgery

Research Activities

Academic Papers

  1. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy, Transplantation, 82(12), 1712-1719, 2006,12,01
  2. Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice, JOURNAL OF CLINICAL INVESTIGATION, 119(11), 3226-3235, NOV 2009
  3. Reg IV Is a Direct Target of Intestinal Transcriptional Factor CDX2 in Gastric Cancer, PLOS ONE, 7(11), NOV 2 2012
  4. The Importance of Stressing the Use of Laparoscopic Instruments in the Initial Training for Laparoscopic Surgery Using Box Trainers: A Randomized Control Study, JOURNAL OF SURGICAL RESEARCH, 174(1), 90-97, MAY 2012
  5. Prognostic criteria in patients with gastrointestinal stromal tumors: a single center experience retrospective analysis, WORLD JOURNAL OF SURGICAL ONCOLOGY, 10, FEB 20 2012
  6. A huge metastatic liver tumor from leiomyosarcoma of the inferior vena cava: report of a case, SURGERY TODAY, 42(5), 505-508, MAY 2012
  7. Achievement of Sustained Viral Response after Switching Treatment from Pegylated Interferon alpha-2b to alpha-2a and Ribavirin in Patients with Recurrence of Hepatitis C Virus Genotype 1 Infection after Liver Transplantation: A Case Report, INTERVIROLOGY, 55(4), 306-310, 2012
  8. Single-port laparoscopic colectomy versus conventional laparoscopic colectomy for colon cancer: a comparison of surgical results, WORLD JOURNAL OF SURGICAL ONCOLOGY, 10, APR 24 2012
  9. Approaching time is important for assessment of endoscopic surgical skills, MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 21(3), 142-149, MAY 2012
  10. Safety and Feasibility of Diet-Treated Donors With Steatotic Livers at the Initial Consultation for Living-Donor Liver Transplantation, TRANSPLANTATION, 93(10), 1024-1030, MAY 27 2012
  11. Renal Vein Extension Using an Autologous Renal Vein in a Living Donor With Double Inferior Vena Cava: A Case Report, TRANSPLANTATION PROCEEDINGS, 44(5), 1446-1449, JUN 2012
  12. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators, NATURE GENETICS, 44(7), 760-U182, JUL 2012
  13. Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells, BREAST CANCER RESEARCH AND TREATMENT, 134(1), 139-155, JUL 2012
  14. Severe necroinflammatory reaction caused by natural killer cell-mediated Fas/Fas ligand interaction and dendritic cells in human hepatocyte chimeric mouse, HEPATOLOGY, 56(2), 555-566, AUG 2012
  15. Liver-intestine cadherin induction by epidermal growth factor receptor is associated with intestinal differentiation of gastric cancer, CANCER SCIENCE, 103(9), 1744-1750, SEP 2012
  16. Prognostic Significance of Antithrombin III Levels for Outcomes in Patients with Hepatocellular Carcinoma After Curative Hepatectomy, ANNALS OF SURGICAL ONCOLOGY, 19(9), 2888-2896, SEP 2012
  17. Primary lung cancer presenting with metastasis to the colon: a case report, WORLD JOURNAL OF SURGICAL ONCOLOGY, 10, JUN 28 2012
  18. Clinical-Scale Isolation of Interleukin-2-Stimulated Liver Natural Killer Cells for Treatment of Liver Transplantation With Hepatocellular Carcinoma, CELL TRANSPLANTATION, 21(7), 1397-1406, 2012
  19. Clinical-Scale Isolation of Interleukin-2-Stimulated Liver Natural Killer Cells for Treatment of Liver Transplantation With Hepatocellular Carcinoma, CELL TRANSPLANTATION, 21(7), 1397-1406, 2012
  20. Preventive effect of G-CSF on acute lung injury via alveolar macrophage regulation, JOURNAL OF SURGICAL RESEARCH, 178(1), 378-384, NOV 2012
  21. The potential of recombinant vesicular stomatitis virus-mediated virotherapy against metastatic colon cancer, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 31(2), 299-306, FEB 2013
  22. Methylation of breast cancer susceptibility gene 1 (BRCA1) predicts recurrence in patients with curatively resected stage I nonsmall cell lung cancer, CANCER, 119(4), 792-798, FEB 15 2013
  23. Detectability of hepatocellular carcinoma by gadoxetate disodium-enhanced hepatic MRI: Tumor-by-tumor analysis in explant livers, JOURNAL OF MAGNETIC RESONANCE IMAGING, 37(3), 684-691, MAR 2013
  24. Surgical treatment for portosystemic encephalopathy in patients with liver cirrhosis: Occlusion of portosystemic shunt in combination with splenectomy, HEPATOLOGY RESEARCH, 43(3), 249-254, MAR 2013
  25. Expression of Recipient CD47 on Rat Insulinoma Cell Xenografts Prevents Macrophage-Mediated Rejection through SIRP alpha Inhibitory Signaling in Mice, PLOS ONE, 8(3), MAR 5 2013
  26. Preservation of peritoneal fibrinolysis owing to decreased transcription of plasminogen activator inhibitor-1 in peritoneal mesothelial cells suppresses postoperative adhesion formation in laparoscopic surgery, SURGERY, 153(3), 344-356, MAR 2013
  27. Synchronous double cancers of primary hepatic adenosquamous carcinoma and hepatocellular carcinoma: report of a case, SURGERY TODAY, 43(4), 418-423, APR 2013
  28. Controlling the bleeding of jejunal varices formed at the site of choledochojejunostomy: report of 2 cases and a review of the literature, SURGERY TODAY, 43(5), 550-555, MAY 2013
  29. Evaluating the correlation between the HUESAD and OSATS scores: Concurrent validity study, MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 22(3), 144-149, 2013
  30. Virtual reality training followed by box training improves the laparoscopic skills of novice surgeons, MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 22(3), 150-156, 2013
  31. Reliability and validity of a new living liver donor quality of life scale, SURGERY TODAY, 43(7), 732-740, JUL 2013
  32. Comparative Analysis of T-Cell Depletion Method for Clinical Immunotherapy-Anti-Hepatitis C Effects of Natural Killer Cells Via Interferon-gamma Production, TRANSPLANTATION PROCEEDINGS, 45(5), 2045-2050, JUN 2013
  33. Adoptive Transfer of Allogeneic Liver Sinusoidal Endothelial Cells Specifically Inhibits T-Cell Responses to Cognate Stimuli, CELL TRANSPLANTATION, 22(9), 1695-1708, 2013
  34. Prevention of recurrence after curative treatment for hepatocellular carcinoma, SURGERY TODAY, 43(12), 1347-1354, DEC 2013
  35. HLA-DR8 subtyping by polymerase chain reaction (PCR)-DNA conformation polymorphism(DCP) analysis; a simple and practical genotyping method., Hiroshima J. Med. Sci., 45(3), 85-92, 19960901
  36. Liver preservation and liver ischemia-reperfusion injury., Transplantation Now, 12(6), 582-587, 19991101
  37. Diagnostic value of non-invasive near-infrared spectroscopy to assess liver viability of brain dead donor., Transplantation Proceedings, 31, 2922-2923, 19990401
  38. Selection of treatment-hepatectomy-, 78(7), 1225-1228, 20010401
  39. Estimation of Graft Blood Flow in Rat Lung Transplantation Using Near-Infrared Spectroscopy, Transplantation Proceedings, 32, 2437-2438, 20000401
  40. Rearterialization of Hepatic Xenografts in the Combination of Hamster-to-Rat, Transplantation Proceedings, 32, 1127-1128, 20000401
  41. Efficacy of HSP72 induction in rat liver by orally administered geranylgeranylacetone, Transplant International, 13(SUPPL.1), 278-281, 20000401
  42. Stable Technique for Reconstruction of Hepatic Artery in Hamster-to-Rat Liver Transplantation, Transplantation Proceedings, 32, 2341-2342, 20000401
  43. Prevention of Warm Ischemic Injury in Rat Liver Transplantation by Geranylgeranylacetone, Transplantation Proceedings, 32, 1615-1616, 20000401
  44. Nondestructive and real-time evaluation of liver viability in brain dead donor for liver transplantation using near-infrared spectroscopy, The Institute of Statistical Research, 13(SUPPL.1), 272-277, 20000401
  45. Simultaneous estimation of pulmonary edema and tissue oxygenation by near-infrared spectroscopy, Transplantation Proceedings, 31, 178-179, 19990401
  46. Novel assessment of acute lung injury by in vivo near-infrared spectroscopy, Am J Resp Crit Care Med, 160(1), 317-323, 19990401
  47. Oral Administration of Geranylgeranylacetone Protects Rat Livers from Warm Ischemic Injury, Transplantation Proceedings, 31, 2918-2919, 19990401
  48. Effect of geranylgeranylacetone against rat liverwarm ischemic repertusion injory, Organ Biology, 6(4), 73-78, 19990401
  49. Augmentation of microchimerism with donor bone marrow infusion in Hamster-to-rat heart xenograft recipient, Transplantation Proceedings, 31, 694-695, 19990401
  50. Novel use of near-infrared spectroscopy to determine cytochrome oxidase a,a3 reactivity of lung impeded by warm ischemia, Transplantation Proceedings, 30, 3361-3363, 19980401
  51. Estimation of lung water content by near-infrared spectroscopy after warm ischemia, Transplantation Proceedings, 30, 3582-3583, 19980401
  52. Expression of bcl-2 homologue mRNAs in rat liver allograft: rejection-induced cell apoptosis is associated with upregulation of bax and bcl-xs expression, Transplant International, 11(SUPPL.1), 284-288, 19980401
  53. Analysis of Bcl-X in Rat Liver Allograft: Rejection-Induced Apoptosis Is Associated with Up-Regulation of Bcl-xs Expression, Transplantation Proceedings, 30, 2941, 19980401
  54. Effects of Deoxyspergualin(DSG) Administered in the Chronic Phase Following Kidney Transplantation, Transplantation Proceedings, 30, 3682-3683, 19980401
  55. Malignant mesothelioma originating in the hepatic falciform ligament : Report of a case, Surgery Today, 28, 929-931, 19980401
  56. Development of Xenogeneic Microchimerism Correlated with Graft Outcome in Hamster-to-Rat Heart Xenotransplantation, Transplantation Proceedings, 30, 2484-2485, 19980401
  57. Dynamic changes in xenogeneic microchimerism after hamster-to-rat lung and heart xenotransplantation, Transplantation Proceedings, 30, 3867-3868, 19980401
  58. Effect of Simultaneous Infusion of Donor Bone Marrow on Hamster-to-Rat Heart Xenotransplantation, Transplantation Proceedings, 30, 3869-3870, 19980401
  59. Prolongation of concordant xenograft survival by treatment with FTY720, Transplantation Proceedings, 30, 4163-4165, 19980401
  60. Relationship of Xenogeneic Microchimerism to Graft Outcome in Hamster-to-Rat Lung Xenotransplantation, J. Heart Lung Transplant., 17, 233-240, 19980401
  61. Role of the bcl-2/bax pathway in hepatocyte apoptosis during acute rejection after rat liver transplantation, Transplant International, 11, 179-184, 19980401
  62. Analysis of apoptosis-associated genes: Fas ligand, Bcl-2 and Bax in the rat liver allograft, Transplantation Proceedings, 30, 22-24, 19980401
  63. Preventive efficacy of 15-Deoxyspergualin against progression of apoptotic cell death in acute rejection after rat liver transplantation, Transplantation Proceedings, 30, 4104-4105, 19980401
  64. Expression of Bcl-2/Bax in RNA in grafted liver during acute rejection after rat liver transplantation, Transplantation Proceedings, 30, 2950-2951, 19980401
  65. Modulation of Kupffer cells affects the metabolism of protease inhibitor administered in cold-preserved liver transplantation, Transplantation Proceedings, 29, 3358-3359, 19970401
  66. Prolongation of hamster-to-rat liver xenograft survival by donor bone marrow augmentation, Transplantation Proceedings, 29(1-2), 925-927, 19970201
  67. Frequent occurrence of hepatocytic apoptosis in acute rejection of the grafted rat liver, Pathology International, 47(8), 518-524, 19970401
  68. Near-infrared spectroscopic method for assessing the tissue oxygenation state of living lung, Am J Respir Crit Care Med, 156(5), 1656-1661, 19970401
  69. Analysis of xenogeneic microchimerism in hamster-to-rat lung xenotransplantation, Transplantation Proceedings, 29, 3505-3507, 19970401
  70. Synergistic effects of nafamostat mesilate rinse and Kupffer cell blockade for rat 1iver preservation, Transplant International, 9, 447-451, 19960401
  71. Optimal pH of UW solution and rinse solution for liver preservation, Transplantation Proceedings, 28, 1891-1892, 19960401
  72. Organ Preservation and evaluation of viability, Organ Biology, 7(3), 43-52, 20000401
  73. High dose of Geranylgeranylacetone accumulate HSP72 mRNA in rat liver, Transplantation Proceedings, 33, 978, 20010401
  74. ROCK inhibitor Y-27632 prevents primary graft non-function caused by warm ischemia/reperfusion in rat liver transplantation, The Institute of Statistical Research, 15(2), 623-629, 20020401
  75. Beneficial effects of a Rho-associated coiled-coli forming protein serine/threonine kinase inhibitor, Y-27632, on survival of recipients in rat liver transplantation following warm ischemia, Transplantation Proceedings, 34, 2643-2644, 20020401
  76. The Role of Mouse Stroma in Rat Haematopoiesis in Xenogeneic Rat/Mouse Bone Marrow Transplantation Chimeras, Transplantation Proceedings, 34, 2759, 20020401
  77. Gasless laparoscopic hepatic resection for cirrhotic patients with solid liver tumors, 12(5), 325-330, 20020401
  78. Enzyme-linked immunospot assay for detecting cells secreting antibodies against human blood group A epitopes, Transplantation Proceedings, 35, 555-556, 20030401
  79. ROCK inhibitor, Y-27632, Inhibits Anoxia-Reoxygenation-Induced Contraction of Hepatic Stellate Cells, Transplantation Proceedings, 35, 111-113, 20030401
  80. Limited Engraftment Capacity of Bone Marrow-Derived Mesenchymal Cells in Xenogeneic Bone Marrow Transplantation, Transplantation Proceedings, 35, 504-505, 20030201
  81. Multiparameter Flow Cytometric Mixed Lymphocyte Reaction Assay Using Fluorescent Cytoplasmic Dye for Assessing Phenotypic Property of T Cells Responding to Allogeneic Stimulation, Transplantation Proceedings, 35, 557-558, 20030401
  82. Prevention of ischemia-reperfusion-induced hepatic microcirculatory disruption by inhibiting stellate cell contraction using rock inhibitor., Transplantation, 75(5), 579-586, 20030301
  83. Novel Method Using Near-Infrared Spectroscopy to Assess Intrahepatic Anastomosis Between Hepatic Veins of Right Lobe Graft in Living-Donor Liver Transplantation, Transplantation Proceedings, 34, 2781, 20020401
  84. NOD/SCID mice engrafted with human peripheral blood group A carbohydrate determinant, Transplant Immunology, 12, 9-18, 20030401
  85. Construction of ectopic xenogeneic bone marrow structure associated with persistent multi-lineage mixed chimerism by engraftment of rat bone marrow plugs into mouse kidney capsules, Xenotransplantation, 10(3), 259-266, 20030401
  86. Resection of Hepatocellular Carcinoma in a Patient with Congenital Anrmaly of the Portal System, Digestive Surgery, 20, 163-165, 20030401
  87. Liver NK Cells Expressing TRAIL Are Toxic Against Self Hepatocytes in Mice, Hepatology, 33(5), 1322-1331, 20040501
  88. Studies on eleven Kidney transplants from non-heart-beating donors, Hiroshima J. Med. Sci., 53(1), 7-11, 20040301
  89. Allochronic overlapping malignancies after renal transplantation in a patient with p53 gene mutation: Report of a case, Surg Today, 34(5), 473-476, 20040501
  90. Involvement of tumor necrosis factor-alpha recptor 1 and tumor necrosis factor-related apoptosisi-inducing ligand-(TRAIL) recptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation, Transplant International, 17(10), 626-633, 20041101
  91. Multiparameter flow cytometric approach for simultaneous evaluation of proliferation and cytokine-secreting activity in T cells responding to allo-stimulation., Immunological Investigations, 33(3), 309-324, 20040801
  92. Differential diagnosisi between graft-versus-host disease and hemophagocytic syndrome after living- related liver transplantation by mixed lymphocyte reaction assay, Journal of Investigative Surgery, 17(4), 197-202, 20040801
  93. Near-infrared-spectroscopic analysis of hepatic hemodynamics and oxygen metabolism after extensive hepatectomy, Medical Science Monitoring, 10(10), 356-361, 20041001
  94. Indications of partial hepatectomy for transplantable hepatocellular carcinoma with compensated cirrhosis, The American Journal of Surgery, 189, 167-172, 20050201
  95. Antibody-and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells, Xenotransplantation, 12(3), 181-188, 20050501
  96. Calcineurin inhibitors block B-1 cell differentiation: the relevance to immunosuppressive treatment in ABO-incompatible transplantation, Transplantation Proceedings, 37(4), 1808-1811, 20050501
  97. Vascular closure staples for portal vein reconstruction in living-donor liver transplantation, The American Journal of Surgery, 190(1), 65-68, 20050401
  98. Low incidence of acute rejection after living-donor liver transplantation:immunologic analyses by mixed lymphocyte reaction using a carboxyfluorescein diacetate succinimidy1 ester labeling technique, Transplantation, 79(9), 1262-1267, 20050501
  99. Liver sinusoidal endothelial cells contribute to alloreactive T-cell tolerance induced by portal venous injection of donor splenocytes, Transpl. Int., 18(2), 237-245, 20050201
  100. Indication of hepatectomy for cirrhotic patients with hepatocellular carcinoma classified as child-pugh class B, World J.Surg. 29(6):734-8., 29(6), 734-738, 20050601
  101. Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma, Hepato-Gastroenterology, 52(64), 1163-1167, 20050701
  102. Studies on post-transplant dyslipidemia in kidney transplant patients, Hiroshima J. Med. Sci., 54(2), 39-45, 20050601
  103. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans., Hepatology, 43(2), 362-372., 20060201
  104. Induction of endotoxin tolerance inhibits alloimmune responses., Transpl Immunol., 16(3-4), 158-165, 20060701
  105. Safety of donor right hepatectomy for adult-to-adult living donor liver transplantation., The Institute of Statistical Research, 19(3), 177-183, 20060301
  106. Radiofrequency-assited Partial splenectomy with a new and simple divice, The American Journal of Surgery, 192, 252-254, 20060801
  107. Liver sinusoidal endothelial cells that endocytose allogeneic cells suppress T cells with indirect allospecificity., J. Immunol., 177(6), 3615-3624, 20060901
  108. Near-infrared spectroscopic analysis of hemodynamics and mitochondrial redox in right lobe grafts in living-donor liver transplantation, Am J Transplant., 6(4), 797-805, 20060401
  109. Clinicopathologic features of poorly differentiated hepatocellular carcinoma., J. Surg. Oncol, 95(4), 311-316, 20070301
  110. Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10years after curative hepatectomy, World J. Surg., 31(2), 345-352., 20070201
  111. Evidence of Immune Tolerance to Blood Group Antigens in a Case of ABO-Incompatible Pediatric Liver Transplantation, Am J Transplant, 7(9), 2190-2194, 20070901
  112. Microsurgical hepatic artery reconstruction during living-donor liver transplantation by using head-mounted surgical binocular system, Transpl Int, 20(11), 970-973, 20071101
  113. The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation, Blood, 110(13), 4546-4575, 20071201
  114. Repeat hepatectomy for recurrent hepatocellular carcinoma, Surgery, 141(5), 589-597, 20070501
  115. Possible therapeutic effect of lipid supplementation on neurological complications in liver transplant recipients, Transpl Int, 20(7), 632-635, 20070401
  116. Should splenectomy be performed for hepatitis C patients undergoing living-donor liver transplantation, J Gastroenterol Hepatol, 22(6), 959-960, 20070601
  117. Biliary Complications after Duct-to-duct Biliary Reconstruction in Living-donor Liver Transplantation : Causes and Treatment, World Journal of Surgery, 31(11), 2222-2229, 20071101
  118. Case report: Splenic artery steal syndrome in living-donor liver transplantation, Transplant Proc, 39(10), 3519-3522, 20071201
  119. Hepatocyte growth factor prevents chronic allograft dysfunction in liver-transplanted rats., Transplantation, 76(5), 761-765, 20030401
  120. Liver sinusoidal endothelial cells have a capacity for inducing nonresponsiveness of T cells across major histocompatibility complex barriers, The Institute of Statistical Research, 18(2), 206-214, 20050201
  121. Evidence of Immune Tolerance to Blood Group Antigens in a Case of ABO-Incompatible Pediatric Liver Transplantation, American Journal of Transplantation, 7(9), 2190-2194, 20070901
  122. Microsurgical hepatic artery reconstruction during living-donor liver transplantation by using head-mounted surgical binocular system, The Institute of Statistical Research, 20(11), 970-973, 20071101
  123. Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: causes and treatment., World Journal of Surgery, 31(11), 2222-2229, 20071101
  124. Repeat hepatectomy for recurrent hepatocellular carcinoma., Surgery, 141(5), 589-597, 20070501
  125. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages., Proc Natl Acad Sci USA, 104(12), 5062-5066, 20070301
  126. Possible therapeutic effect of lipid supplementation on neurological complications in liver transplant recipients., The Institute of Statistical Research, 20(7), 632-635, 20070701
  127. Should splenectomy be performed for hepatitis C patients undergoing living-donor liver transplantation?, J Gastroenterol Hepatol, 22(6), 959-960, 20070201
  128. The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation., Blood, 110(13), 4567-4575, 20071201
  129. Splenic artery steal syndrome in living donor liver transplantation: a case report., Transplantation Proceedings, 39(10), 3519-3522, 20071201
  130. Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: causes and treatment., World J Surg., 31(11), 2222-9., 20071101
  131. Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: causes and treatment., World J Surg, 31(11), 2222-9, 20071101
  132. Hepatic arterial infusion of liposomal amphotericin B for multiple fungal abscesses in the liver of a patient with chronic granulomatous disease, 51(5), 345, 20100501
  133. A New Method for Intraluminal Gastrointestinal Stromal Tumor Resection Using Laparoscopic Seromuscular Dissection Technique, Digestive Surgery, 27(6), 461-465, 20101201
  134. Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis, World J Surg Oncol, 8, 40, 20100501
  135. Immunological Property of Antibodies against N-Glycolylneuraminic Acid Epitopes in Cytidine Monophospho-N-Acetylneuraminic Acid Hydroxylase-Deficient Mice, 20100301
  136. Quantification of T-Cell Proliferation for Individualizing Immunosuppressive Therapy for Transplantation Patients, 20100101
  137. Idiopathic granulomatous gastritis resembling a gastrointestinal stromal tumor., Case Rep Gastroenterol, 6(2), 502-9, 20120701
  138. Safety and Efficacy of Laparoscopy-Assisted Gastrectomy after Endoscopic Submucosal Dissection for Early Gastric Cancer: A Retrospective Report., Journal of Cancer Therapy, 4(1), 54-60, 20130401
  139. IL28B SNP of donors and recipients can predict virological response to PEGIFN/RBV therapy in patients with recurrent hepatitis C after living donor liver transplantation., J Gastroenterol Hepatol., 20120901
  140. Incidental renal cell carcinoma presenting in a renal transplant recipient with autosomal dominant polycystic kidney disease: a case report., J Med Case Rep, 13, 154, 20120601
  141. Hepatocellular carcinoma and focal nodular hyperplasia of the liver in a glycogen storage disease patient., World J Hepatol., 4, 191-195, 20120601
  142. Idiopathic granulomatous gastritis resembling a gastrointestinal stromal tumor., Case Rep Gastroenterol., 6, 502-509, 20120501
  143. Impact of laparoscopic experience on the proficiency gain of urological surgeons in robot-assisted surgery., J Endourol., 20120801
  144. Submucosal invasive micropapillary carcinoma of the colon with massive lymph node metastases: a case report, Case Rep Oncol, 5, 608-615, 20120901
  145. Three models for predicting the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients., Breast Cancer., 20130101
  146. Safety and Efficacy of Laparoscopy-Assisted Gastrectomy after Endoscopic Submucosal Dissection for Early Gastric Cancer: A Retrospective Report, journal of cancer therapy, 4, 54-56, 20130101
  147. Leiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report, BMC Gastroenterol, 12, 98, 20120701
  148. Triple-Tube-Ostomy: A Novel Technique for the Surgical Treatment of Iatrogenic Duodenal Perforation, Case Reports in Gastroenterology, 5(3), 672-679, 20111201
  149. Thoracoscopic-assisted repair of a Bochdalek hernia in an adult: a case report, J Med Case Reports, 4(1), 366, 20101101
  150. Preliminary trial of adjuvant surgery for advanced gastric cancer, Oncol Lett, 1, 743-747, 20100501
  151. Rearterialization of hepatic xenografts in the combination of hamster-to-rat, TRANSPLANTATION PROCEEDINGS, 32(5), 1127-1128, AUG 2000
  152. Prevention of warm ischemic injury in rat liver transplantation by geranylgeranylacetone, TRANSPLANTATION PROCEEDINGS, 32(7), 1615-1616, NOV 2000
  153. Stable technique for reconstruction of hepatic artery in hamster-to-rat liver transplantation, TRANSPLANTATION PROCEEDINGS, 32(7), 2341-2342, NOV 2000
  154. Estimation of graft blood flow in rat lung transplantation using near-infrared spectroscopy, TRANSPLANTATION PROCEEDINGS, 32(7), 2437-2438, NOV 2000
  155. High dose of geranylgeranylacetone accumulate HSP72 mRNA in rat liver, TRANSPLANTATION PROCEEDINGS, 33(1-2), 978-978, FEB-MAR 2001
  156. Geranylgeranylacetone, a heat shock protein inducer, prevents primary graft nonfunction in rat liver transplantation, TRANSPLANTATION, 72(2), 184-189, JUL 27 2001
  157. ROCK inhibitor, Y-27632, inhibits anoxia-reoxygenation-induced contraction of hepatic stellate cells, TRANSPLANTATION PROCEEDINGS, 35(1), 111-113, FEB 2003
  158. Gasless laparoscopic hepatic resection for cirrhotic patients with solid liver tumors, SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 12(5), 325-330, OCT 2002
  159. Beneficial effects of a Rho-associated coiled-coli forming protein serine/threonine kinase inhibitor, Y-27632, on survival of recipients in rat liver transplantation following warm ischemia, TRANSPLANTATION PROCEEDINGS, 34(7), 2643-2644, NOV 2002
  160. The role of mouse stroma in rat haematopoiesis in xenogeneic rat/mouse bone marrow transplantation chimeras, TRANSPLANTATION PROCEEDINGS, 34(7), 2759-2759, NOV 2002
  161. Novel method using near-infrared spectroscopy to assess intrahepatic anastomosis between hepatic veins of right lobe graft in living-donor liver transplantation, TRANSPLANTATION PROCEEDINGS, 34(7), 2781-2781, NOV 2002
  162. ROCK inhibitor Y-27632 prevents primary graft non-function caused by warm ischemia/reperfusion in rat liver transplantation, TRANSPLANT INTERNATIONAL, 15(12), 623-629, DEC 2002
  163. Hepatocyte growth factor prevents chronic allograft dysfunction in liver-transplanted rats, TRANSPLANTATION, 76(5), 761-765, SEP 15 2003
  164. Intraoperative near-infrared spectroscopy for evaluating hepatic venous outflow in living-donor right lobe liver., TRANSPLANTATION, 76(5), 791-797, SEP 15 2003
  165. Limited engraftment capacity of bone marrow-derived mesenchymal cells in xenogeneic bone marrow transplantation, TRANSPLANTATION PROCEEDINGS, 35(1), 504-505, FEB 2003
  166. Enzyme-linked immunospot assay for detecting cells secreting antibodies against human blood group A epitopes, TRANSPLANTATION PROCEEDINGS, 35(1), 555-556, FEB 2003
  167. Multiparameter flow cytometric mixed lymphocyte reaction assay using fluorescent cytoplasmic dye for assessing phenotypic property of T cells responding to allogeneic stimulation, TRANSPLANTATION PROCEEDINGS, 35(1), 557-558, FEB 2003
  168. B cell tolerance to xenoantigens, XENOTRANSPLANTATION, 10(2), 98-106, MAR 2003
  169. Prevention of ischemia-reperfusion-induced hepatic microcirculatory disruption by inhibiting stellate cell contraction using rock inhibitor., TRANSPLANTATION, 75(5), 579-586, MAR 15 2003
  170. Resection of hepatocellular carcinoma in a patient with congenital anomaly of the portal system, DIGESTIVE SURGERY, 20(2), 163-165, 2003
  171. Construction of ectopic xenogeneic bone marrow structure associated with persistent multi-lineage mixed chimerism by engraftment of rat bone marrow plugs into mouse kidney capsules, XENOTRANSPLANTATION, 10(3), 259-266, MAY 2003
  172. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant, TRANSPLANT IMMUNOLOGY, 12(1), 9-18, OCT-NOV 2003
  173. Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice, HEPATOLOGY, 39(5), 1321-1331, MAY 2004
  174. Allochronic overlapping malignancies after renal transplantation in a patient with p53 gene mutation: Report of a case, SURGERY TODAY, 34(5), 473-476, MAY 2004
  175. Differential diagnosis between graft-versus-host disease and hemophagocytic syndrome after living-related liver transplantation by mixed lymphocyte reaction assay, JOURNAL OF INVESTIGATIVE SURGERY, 17(4), 197-202, JUL-AUG 2004
  176. Multiparameter flow cytometric approach for simultaneous evaluation of proliferation and cytokine-secreting activity in T cells responding to allo-stimulation, IMMUNOLOGICAL INVESTIGATIONS, 33(3), 309-324, 2004
  177. Near-infrared spectroscopic analysis of hepatic hemodynamics and oxygen metabolism after extensive hepatectomy, MEDICAL SCIENCE MONITOR, 10(10), BR356-BR361, OCT 2004
  178. Involvement of tumor necrosis factor-alpha receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation, TRANSPLANT INTERNATIONAL, 17(10), 626-633, OCT 2004
  179. Indications of partial hepatectomy for transplantable hepatocellular carcinoma with compensated cirrhosis, AMERICAN JOURNAL OF SURGERY, 189(2), 167-172, FEB 2005
  180. Liver sinusoidal endothelial cells have a capacity for inducing nonresponsiveness of T cells across major histocompatibility complex barriers, TRANSPLANT INTERNATIONAL, 18(2), 206-214, FEB 2005
  181. Liver sinusoidal endothelial cells contribute to alloreactive T-cell tolerance induced by portal venous injection of donor splenocytes, TRANSPLANT INTERNATIONAL, 18(2), 237-245, FEB 2005
  182. Antibody- and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells, XENOTRANSPLANTATION, 12(3), 181-188, MAY 2005
  183. Low incidence of acute rejection after living-donor liver transplantation: Immunologic analyses by mixed lymphocyte reaction using a carboxyfluorescein diacetate succinimidyl ester labeling technique, TRANSPLANTATION, 79(9), 1262-1267, MAY 15 2005
  184. Calcineurin inhibitors block B-1 cell differentiation: The relevance to immunosuppressive treatment in ABO-incompatible transplantation, TRANSPLANTATION PROCEEDINGS, 37(4), 1808-1811, MAY 2005
  185. Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma, HEPATO-GASTROENTEROLOGY, 52(64), 1163-1167, JUL-AUG 2005
  186. Liver sinusoidal endothelial cells tolerize T cells across MHC barriers in mice, JOURNAL OF IMMUNOLOGY, 175(1), 139-146, JUL 1 2005
  187. Vascular closure staples for portal vein reconstruction in living-donor liver transplantation, AMERICAN JOURNAL OF SURGERY, 190(1), 65-68, JUL 2005
  188. Indication of hepatectomy for cirrhotic patients with hepatocellular carcinoma classified as Child-Pugh class B, WORLD JOURNAL OF SURGERY, 29(6), 734-738, JUN 2005
  189. B cell tolerance and xenotransplantation, CURRENT OPINION IN ORGAN TRANSPLANTATION, 10(3), 252-258, SEP 2005
  190. Safety of donor right hepatectomy for adult-to-adult living donor liver transplantation, TRANSPLANT INTERNATIONAL, 19(3), 177-183, MAR 2006
  191. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans, HEPATOLOGY, 43(2), 362-372, FEB 2006
  192. Near-infrared spectroscopic analysis of hemodynamics and mitochondrial redox in right lobe grafts in living-donor liver transplantation, AMERICAN JOURNAL OF TRANSPLANTATION, 6(4), 797-805, APR 2006
  193. Radiofrequency-assisted partial splenectomy with a new and simple device, AMERICAN JOURNAL OF SURGERY, 192(2), 252-254, AUG 2006
  194. Liver sinusoidal endothelial cells that endocytose allogeneic cells suppress T cells with indirect allospecificity, JOURNAL OF IMMUNOLOGY, 177(6), 3615-3624, SEP 15 2006
  195. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy, TRANSPLANTATION, 82(12), 1712-1719, DEC 27 2006
  196. Induction of endotoxin tolerance inhibits alloimmune responses, TRANSPLANT IMMUNOLOGY, 16(3-4), 158-165, NOV 2006
  197. Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10 years after curative hepatectomy, WORLD JOURNAL OF SURGERY, 31(2), 345-352, FEB 2007
  198. Clinicopathologic features of poorly differentiated hepatocellular carcinoma, JOURNAL OF SURGICAL ONCOLOGY, 95(4), 311-316, MAR 15 2007
  199. Role for CD47-SIRP alpha signaling in xenograft rejection by macrophages, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 104(12), 5062-5066, MAR 20 2007
  200. Repeat hepatectomy for recurrent hepatocellular carcinoma, SURGERY, 141(5), 589-597, MAY 2007
  201. Possible therapeutic effect of lipid supplementation on neurological complications in liver transplant recipients, TRANSPLANT INTERNATIONAL, 20(7), 632-635, JUL 2007
  202. alpha 1,3-galactosyltransferase gene-knockout pigs for xenotransplantation: Where do we go from here?, TRANSPLANTATION, 84(1), 1-7, JUL 15 2007
  203. Evidence of immune tolerance to blood group antigens in a case of ABO-incompatible pediatric liver transplantation, AMERICAN JOURNAL OF TRANSPLANTATION, 7(9), 2190-2194, SEP 2007
  204. Splenic artery steal syndrome in living donor liver transplantation: A case report, TRANSPLANTATION PROCEEDINGS, 39(10), 3519-3522, DEC 2007
  205. Microsurgical hepatic artery reconstruction during living-donor liver transplantation by using head-mounted surgical binocular system, TRANSPLANT INTERNATIONAL, 20(11), 970-973, NOV 2007
  206. Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: Causes and treatment, WORLD JOURNAL OF SURGERY, 31(11), 2222-2229, NOV 2007
  207. Reconstruction of the middle hepatic vein tributaries draining segments V and VIII of a right liver graft by using the recipient's own middle hepatic vein and vascular closure staples, SURGERY TODAY, 38(3), 289-291, MAR 2008
  208. The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation, BLOOD, 110(13), 4567-4575, DEC 15 2007
  209. Deubiquitylation of histone H2A activates transcriptional initiation via trans-histone cross-talk with H3K4 di- and trimethylation, GENES & DEVELOPMENT, 22(1), 37-49, JAN 1 2008
  210. Current status of liver transplantation across ABO blood-type barrier, JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 15(2), 131-138, MAR 2008
  211. Perioperative management of benign hepatic tumors in patients with glycogen storage disease type Ia, JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 15(2), 200-203, MAR 2008
  212. Hepatic venous outflow obstruction after right lateral sector living-donor liver transplantation, treated by insertion of an expandable metallic stent, JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 15(2), 228-231, MAR 2008
  213. Role of invariant natural killer T cells in liver sinusoidal endothelian cell-induced immunosuppression among T cells with indirect allospecificty, TRANSPLANTATION, 85(7), 1060-1064, APR 15 2008
  214. Comparative study of the Japan Integrated Stage (JIS) and modified JIS score as a predictor of survival after hepatectomy for hepatocellular carcinoma, JOURNAL OF GASTROENTEROLOGY, 43(5), 369-377, 2008
  215. Engraftment of human hepatocytes in the livers of rats bearing bone marrow reconstructed with immunodeficient mouse bone marrow cells, XENOTRANSPLANTATION, 15(4), 235-245, JUL-AUG 2008
  216. Laminin gamma 2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells, GASTROENTEROLOGY, 137(1), 242-252, JUL 2009
  217. Prophylaxis against Recurrence of HBV Hepatitis after Living-donor Liver Transplantation, HEPATO-GASTROENTEROLOGY, 55(86-87), 1746-1749, SEP-OCT 2008
  218. Reconstruction of the Middle Hepatic Vein Tributary with Resection of the Middle Hepatic Vein Trunk: Report of a Case, HEPATO-GASTROENTEROLOGY, 55(86-87), 1773-1775, SEP-OCT 2008
  219. Retroperitoneal abscess complicated with necrotizing fasciitis of the thigh in a patient with sigmoid colon cancer, WORLD JOURNAL OF SURGICAL ONCOLOGY, 7, OCT 7 2009
  220. Using Recipient's Middle Hepatic Vein for Drainage of the Right Paramedian Sector in Right Liver Graft, TRANSPLANTATION, 86(11), 1565-1571, DEC 15 2008
  221. Significant Correlation Between Spleen Volume and Thrombocytopenia in Liver Transplant Patients: A Concept for Predicting Persistent Thrombocytopenia, LIVER TRANSPLANTATION, 15(2), 208-215, FEB 2009
  222. Abscess in the inguinal hernial sac after peritonitis surgery: A case report, WORLD JOURNAL OF GASTROENTEROLOGY, 15(8), 1007-1009, FEB 28 2009
  223. ABO-blood type incompatible living donor liver transplantation in a patient with Budd-Chiari Syndrome secondary to essential thrombocythemia, HEPATOLOGY RESEARCH, 39(5), 520-524, MAY 2009
  224. Hepatectomy for Hepatocellular Carcinoma in Elderly Patients Aged 75 Years or More, JOURNAL OF GASTROINTESTINAL SURGERY, 13(4), 695-701, APR 2009
  225. Successful hepatitis B vaccination in liver transplant recipients with donor-specific hyporesponsiveness, TRANSPLANT INTERNATIONAL, 22(8), 805-813, AUG 2009
  226. Multidisciplinary treatment including sorafenib stabilized the bone metastases of renal cell carcinoma in an immunosuppressed renal transplant recipient, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 14(5), 465-467, OCT 2009
  227. Suppression of Hepatocellular Carcinoma Recurrence After Rat Liver Transplantation by FTY720, a Sphingosine-1-Phosphate Analog, TRANSPLANTATION, 88(8), 980-986, OCT 27 2009
  228. Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis, WORLD JOURNAL OF SURGICAL ONCOLOGY, 8, MAY 19 2010
  229. Hybrid Hand-Assisted Colectomy for Transverse Colon Cancer: A Useful Technique for Non-Expert Laparoscopic Surgeons, WORLD JOURNAL OF SURGERY, 33(12), 2683-2687, DEC 2009
  230. Remission of Splenic Volume in the Recipient During the Course of Adult-to-Adult Living Donor Liver Transplantation: Evaluation Using Multislice Computed Tomography and Semiautomatic Software, TRANSPLANTATION PROCEEDINGS, 41(9), 3772-3774, NOV 2009
  231. Successful Living Donor Left Liver Transplantation by Using Liver Graft With Multiple Large Cysts: A Case Report, TRANSPLANTATION PROCEEDINGS, 41(9), 3923-3926, NOV 2009
  232. Scientific assessment of endoscopic surgical skills, MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 19(1), 30-34, FEB 2010
  233. Immunological Property of Antibodies against N-Glycolylneuraminic Acid Epitopes in Cytidine Monophospho-N-Acetylneuraminic Acid Hydroxylase-Deficient Mice, JOURNAL OF IMMUNOLOGY, 184(6), 3269-3275, MAR 15 2010
  234. Comparison of immunohistochemistry assays and real-time reverse transcription-polymerase chain reaction for analyzing hormone receptor status in human breast carcinoma, PATHOLOGY INTERNATIONAL, 60(4), 305-315, APR 2010
  235. Gastrointestinal stromal tumors of the small intestine in pediatric populations: a case report and literature review, PEDIATRIC SURGERY INTERNATIONAL, 26(6), 649-654, JUN 2010
  236. Determination of the precursor frequency and the reaction intensity of xenoreactive human T lymphocytes, XENOTRANSPLANTATION, 17(3), 188-196, MAY-JUN 2010
  237. Alterations in portal vein blood pH, hepatic functions, and hepatic histology in a porcine carbon dioxide pneumoperitoneum model, SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 24(7), 1693-1700, JUL 2010
  238. CDX2 Regulates Multidrug Resistance 1 Gene Expression in Malignant Intestinal Epithelium, CANCER RESEARCH, 70(17), 6767-6778, SEP 1 2010
  239. Prolongation of interferon therapy for recurrent hepatitis C after living donor liver transplantation: Analysis of predictive factors of sustained virological response, including amino acid sequence of the core and NS5A regions of hepatitis C virus, SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 45(12), 1488-1496, DEC 2010
  240. Preliminary trial of adjuvant surgery for advanced gastric cancer, ONCOLOGY LETTERS, 1(4), 743-747, JUL-AUG 2010
  241. Deficiency of N-glycolylneuraminic acid and Gal alpha 1-3Gal beta 1-4GlcNAc epitopes in xenogeneic cells attenuates cytotoxicity of human natural antibodies, XENOTRANSPLANTATION, 17(6), 440-448, NOV-DEC 2010
  242. A New Method for Intraluminal Gastrointestinal Stromal Tumor Resection Using Laparoscopic Seromuscular Dissection Technique, DIGESTIVE SURGERY, 27(6), 461-465, 2010
  243. Possibility of Adoptive Immunotherapy With Peripheral Blood-derived CD3(-)CD56(+) and CD3(+)CD56(+) Cells for Inducing Antihepatocellular Carcinoma and Antihepatitis C Virus Activity, JOURNAL OF IMMUNOTHERAPY, 34(2), 137-146, MAR 2011
  244. Splenectomy in Chronic Hepatic Disorders: Portal Vein Thrombosis and Improvement of Liver Function, DIGESTIVE SURGERY, 28(1), 9-14, 2011
  245. Therapeutic Potential of Propagated Hepatocyte Transplantation in Liver Failure, JOURNAL OF SURGICAL RESEARCH, 167(1), E29-E37, MAY 2011
  246. Selection Criteria for Hepatectomy in Patients with Hepatocellular Carcinoma Classified as Child-Pugh Class B, WORLD JOURNAL OF SURGERY, 35(4), 834-841, APR 2011
  247. Malignant peripheral nerve sheath tumor arising from the greater omentum: Case report, WORLD JOURNAL OF SURGICAL ONCOLOGY, 9, MAR 21 2011
  248. Treatment Strategy for Early Hepatocellular Carcinomas: Comparison of Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization and Surgical Resection, JOURNAL OF SURGICAL ONCOLOGY, 104(1), 3-9, JUL 1 2011
  249. Significance of Platelet Count in the Outcomes of Hepatectomized Patients with Hepatocellular Carcinoma Exceeding the Milan Criteria, JOURNAL OF GASTROINTESTINAL SURGERY, 15(7), 1173-1181, JUL 2011
  250. Relationship between the cAMP levels in leukocytes and the cytokine balance in patients surviving gram negative bacterial pneumonia, JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 48(2), 134-141, MAR 2 2011
  251. Tumor-related factors do not influence the prognosis of solitary hepatocellular carcinoma after partial hepatectomy, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 18(5), 689-699, SEP 2011
  252. Long-Term Outcome of Hepatic Artery Reconstruction during Living-Donor Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 43(5), 1720-1724, JUN 2011
  253. Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs), PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 108(28), 11542-11547, JUL 12 2011
  254. Kinetics of Cellular and Humoral Immunity in a Successful Case of Positive Crossmatch Kidney Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 43(6), 2411-2414, JUL-AUG 2011
  255. Impact of Adjuvant Immunotherapy Using Liver Allograft-Derived Lymphocytes on Bacteremia in Living-Donor Liver Transplantation, TRANSPLANTATION, 92(5), 575-580, SEP 2011
  256. External Validation of Two Nomograms for Predicting Patient Survival After Hepatic Resection for Metastatic Colorectal Cancer, WORLD JOURNAL OF SURGERY, 35(10), 2275-2282, OCT 2011
  257. Adequate lymph node examination is essential to ensure the prognostic value of the lymph node ratio in patients with stage III colorectal cancer, SURGERY TODAY, 41(10), 1370-1379, OCT 2011
  258. IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma, JOURNAL OF VIRAL HEPATITIS, 18(10), E550-E560, OCT 2011
  259. Eradication of hepatitis C virus genotype 1 after liver transplantation by interferon therapy before surgery: Report of three patients with analysis of interleukin-28 polymorphism, hepatitis C virus core region and interferon-sensitivity determining region, HEPATOLOGY RESEARCH, 41(11), 1126-1131, NOV 2011
  260. Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liver, JOURNAL OF HEPATOLOGY, 56(1), 146-152, JAN 2012
  261. Impact of Pegylated Interferon Therapy on Outcomes of Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Hepatic Resection, ANNALS OF SURGICAL ONCOLOGY, 19(2), 418-425, FEB 2012
  262. Memorial Sloan-Kettering Cancer Center Nomogram to predict the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients, SURGERY TODAY, 42(3), 245-249, FEB 2012
  263. An Anti-Wnt5a Antibody Suppresses Metastasis of Gastric Cancer Cells In Vivo by Inhibiting Receptor-Mediated Endocytosis, MOLECULAR CANCER THERAPEUTICS, 11(2), 298-307, FEB 2012
  264. Human CD47 Expression Permits Survival of Porcine Cells in Immunodeficient Mice That Express SIRP alpha Capable of Binding to Human CD47, CELL TRANSPLANTATION, 20(11-12), 1915-1920, 2011
  265. No Impact of Perioperative Blood Transfusion on Recurrence of Hepatocellular Carcinoma after Hepatectomy, WORLD JOURNAL OF SURGERY, 36(3), 651-658, MAR 2012
  266. SINGLE-INCISION LAPAROSCOPIC COLECTOMY USING THE GELPORT SYSTEM FOR EARLY COLON CANCER, SCANDINAVIAN JOURNAL OF SURGERY, 101(1), 16-20, 2012
  267. Optimization of Immunosuppressive Therapy Based on a Multiparametric Mixed Lymphocyte Reaction Assay Reduces Infectious Complications and Mortality in Living Donor Liver Transplant Recipients, TRANSPLANTATION PROCEEDINGS, 44(2), 555-559, MAR 2012
  268. Complex Vascular Reconstruction Using Donor's Vessel Grafts in Orthotopic Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 44(2), 574-578, MAR 2012
  269. Identification of patients likely to benefit from metastasectomy in stage IV colorectal cancer, INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 27(10), 1339-1346, OCT 2012
  270. Impact of Laparoscopic Experience on the Proficiency Gain of Urologic Surgeons in Robot-Assisted Surgery, JOURNAL OF ENDOUROLOGY, 26(12), 1635-1638, DEC 2012
  271. Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 27(9), 1467-1472, SEP 2012
  272. Face, Content and Concurrent Validity of the Mimic (R) dV-Trainer for Robot-Assisted Endoscopic Surgery: A Prospective Study, EUROPEAN SURGICAL RESEARCH, 50(3-4), 292-300, 2013
  273. Procalcitonin as a predictive marker for surgical site infection in elective colorectal cancer surgery, LANGENBECKS ARCHIVES OF SURGERY, 398(6), 833-839, AUG 2013
  274. Inferior vena cava tumor thrombus that directly infiltrated from paracaval lymph node metastases in a patient with recurrent hepatocellular carcinoma, WORLD JOURNAL OF SURGICAL ONCOLOGY, 11, AUG 6 2013
  275. Blockade of invariant TCR-CD1d interaction specifically inhibits antibody production against blood group A carbohydrates, BLOOD, 122(15), 2582-2590, OCT 10 2013
  276. Surgical treatment for isolated inguinal lymph node metastasis in lower rectal adenocarcinoma patients improves outcome, INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 28(12), 1675-1680, DEC 2013
  277. Effect of Left Colonic Artery Preservation on Anastomotic Leakage in Laparoscopic Anterior Resection for Middle and Low Rectal Cancer, WORLD JOURNAL OF SURGERY, 37(12), 2935-2943, DEC 2013
  278. The USP21 Short Variant (USP21SV) Lacking NES, Located Mostly in the Nucleus In Vivo, Activates Transcription by Deubiquitylating ubH2A In Vitro, PLOS ONE, 8(11), NOV 22 2013
  279. Production of anti-ABO blood group antibodies after minor ABO-incompatible bone marrow transplantation in NOD/SCID/ gamma(c)(null) mice, CLINICAL TRANSPLANTATION, 27(6), E702-E708, NOV 2013
  280. Overexpression of Hypoxia Inducible Factor-1 Alpha is an Independent Risk Factor for Recurrence After Curative Resection of Colorectal Liver Metastases, ANNALS OF SURGICAL ONCOLOGY, 20, S527-S536, DEC 2013
  281. Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 110(51), 20699-20704, DEC 17 2013
  282. Potential Benefit of Mixed Lymphocyte Reaction Assay-based Immune Monitoring After Living Donor Liver Transplantation for Recipients With Autoimmune Hepatitis, TRANSPLANTATION PROCEEDINGS, 46(3), 785-789, APR 2014
  283. Attenuation of Portal Hypertension by Continuous Portal Infusion of PGE1 and Immunologic Impact in Adult-to-Adult Living-Donor Liver Transplantation, TRANSPLANTATION, 95(12), 1521-1527, JUN 27 2013
  284. A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report, WORLD JOURNAL OF SURGICAL ONCOLOGY, 12, FEB 27 2014
  285. High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer, INTERNATIONAL JOURNAL OF CANCER, 134(8), 1926-1934, APR 15 2014
  286. Association of Increased Indoleamine 2, 3-Dioxygenase With Impaired Natural Killer Cell Activity in Hemodialysis Patients, THERAPEUTIC APHERESIS AND DIALYSIS, 18(1), 19-23, FEB 2014
  287. Colonoscopy as a tool for evaluating colorectal tumor development in a mouse model, INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 29(2), 217-223, FEB 2014
  288. Clinical Efficacy of Simultaneous Splenectomy in Liver Transplant Recipients With Hepatitis C Virus, TRANSPLANTATION PROCEEDINGS, 46(3), 770-773, APR 2014
  289. Bile CXC Motif Chemokine 10 Levels Correlate With Anti-donor Cytotoxic T Cell Responses After Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 46(3), 790-793, APR 2014
  290. Risk Factors for Development of New-Onset Diabetes Mellitus and Progressive Impairment of Glucose Metabolism After Living-Donor Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 46(3), 865-869, APR 2014
  291. Multiple Hepatic Vein Reconstruction Using an All-in-one Sleeve Patch Graft Technique in Living Donor Liver Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 46(3), 982-985, APR 2014
  292. Ischemia-reperfusion injury in patients with fatty liver and the clinical impact of steatotic liver on hepatic surgery, SURGERY TODAY, 44(9), 1611-1625, SEP 2014
  293. The Usefulness of Preoperative 18FDG Positron-Emission Tomography and Computed Tomography for Predicting the Malignant Potential of Gastrointestinal Stromal Tumors, DIGESTIVE SURGERY, 31(2), 79-86, 2014
  294. Transcatheter arterial chemoembolization with an interventional-CT system for recurrent hepatocellular carcinoma after living donor liver transplantation, HEPATO-GASTROENTEROLOGY, 61(133), 1387-1392, JUL-AUG 2014
  295. Three models for predicting the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients, BREAST CANCER, 21(5), 571-575, SEP 2014
  296. Validation of a novel basic virtual reality simulator, the LAP-X, for training basic laparoscopic skills, MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 23(5), 287-293, OCT 2014
  297. Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation, HEPATOLOGY RESEARCH, 44(12), 1259-1264, NOV 2014
  298. Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis, WORLD JOURNAL OF GASTROENTEROLOGY, 21(6), 1982-1988, FEB 14 2015
  299. Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells, INTERNATIONAL JOURNAL OF CANCER, 136(4), E3-E13, FEB 15 2015
  300. Rho-Kinase Inhibitor Targeting the Liver Prevents Ischemia/Reperfusion Injury in the Steatotic Liver Without Major Systemic Adversity in Rats, LIVER TRANSPLANTATION, 21(1), 123-131, JAN 2015
  301. Impact of alloimmune T cell responses on hepatitis C virus replication in liver transplant recipients, HUMAN IMMUNOLOGY, 75(12), 1259-1267, DEC 2014
  302. Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity, Nature Communications, 6, JAN 2015
  303. Impact of Rituximab Desensitization on Blood-Type-Incompatible Adult Living Donor Liver Transplantation: A Japanese Multicenter Study, AMERICAN JOURNAL OF TRANSPLANTATION, 14(1), 102-114, JAN 2014
  304. Hypoxia-mediated CD24 expression is correlated with gastric cancer aggressiveness by promoting cell migration and invasion, CANCER SCIENCE, 105(11), 1411-1420, NOV 2014
  305. Quantitative Effect of Natural Killer-Cell Licensing on Hepatocellular Carcinoma Recurrence after Curative Hepatectomy, CANCER IMMUNOLOGY RESEARCH, 2(12), 1142-1147, DEC 2014
  306. Initial experiences of robotic versus conventional laparoscopic surgery for colorectal cancer, focusing on short-term outcomes: a matched case-control study, WORLD JOURNAL OF SURGICAL ONCOLOGY, 13, MAR 12 2015
  307. Avoiding restorative proctocolectomy for colorectal cancer in patients with ulcerative colitis based on preoperative diagnosis involving p53 immunostaining: report of a case, WORLD JOURNAL OF SURGICAL ONCOLOGY, 13, MAR 26 2015
  308. Fasting Enhances TRAIL-Mediated Liver Natural Killer Cell Activity via HSP70 Upregulation, PLOS ONE, 9(10), OCT 30 2014
  309. Retention of robot-assisted surgical skills in urological surgeons acquired using Mimic dV-Trainer, CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 8(7-8), E493-E497, JUL 2014
  310. Intrahepatic triglyceride measurement and estimation of viability in rat fatty livers by near-infrared spectroscopy, HEPATOLOGY RESEARCH, 45(4), 470-479, APR 2015
  311. The significance of spatial cognitive ability in robot-assisted surgery, SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 29(5), 1130-1136, MAY 2015
  312. Two Patients Treated With Simeprevir Plus Pegylated-Interferon and Ribavirin Triple Therapy for Recurrent Hepatitis C After Living Donor Liver Transplantation: Case Report, TRANSPLANTATION PROCEEDINGS, 47(3), 809-814, APR 2015
  313. Methylated DLX4 Predicts Response to Pathologic Stage I Non-Small Cell Lung Cancer Resection, ANNALS OF THORACIC SURGERY, 99(5), 1746-1754, MAY 2015
  314. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases, WORLD JOURNAL OF SURGICAL ONCOLOGY, 13, APR 24 2015
  315. Hepatic Sclerosed Hemangioma: a case report and review of the literature, BMC SURGERY, 15, APR 17 2015
  316. Laparoscopic Versus Open Surgery for Colorectal Cancer in Elderly Patients: A Multicenter Matched Case-Control Study, ANNALS OF SURGICAL ONCOLOGY, 22(6), 2040-2050, JUN 2015
  317. Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease, LANGENBECKS ARCHIVES OF SURGERY, 400(4), 471-476, MAY 2015
  318. Administration of Antithrombin III Attenuates Posthepatectomy Liver Failure in Hepatocellular Carcinoma, DIGESTIVE SURGERY, 32(3), 173-180, 2015
  319. An evaluation of the endoscopic surgical skills assessment using a video analysis software program, SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 29(7), 1804-1808, JUL 2015
  320. Small bowel obstruction due to an unconjugated ursodeoxycholic acid enterolith following living donor liver transplantation: Report of a case, HEPATOLOGY RESEARCH, 45(7), 818-822, JUL 2015
  321. Chlorinated Water Modulates the Development of Colorectal Tumors with Chromosomal Instability and Gut Microbiota in Apc-Deficient Mice, PLOS ONE, 10(7), JUL 17 2015
  322. Oxaliplatin and molecular-targeted drug therapies improved the overall survival in colorectal cancer patients with synchronous peritoneal carcinomatosis undergoing incomplete cytoreductive surgery, SURGERY TODAY, 45(8), 986-992, AUG 2015
  323. Sustained virological response to antiviral therapy improves survival rate in patients with recurrent hepatitis C virus infection after liver transplantation, Hepatology Research, 2014,NOV,5
  324. A case of gastric cancer following living donor liver transplantation, Hiroshima J Med Sci, 63(1-3), 23-26, 2014,Sep
  325. Body mass index as a predictor of postoperative complications in loop ileostomy closure after rectal resection in Japanese patients., Hiroshima J Med Sci, 63(4), 33-38, 2014,Dec
  326. Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers., PLoS One, 9(12), e114263. doi: 10.1371, 2014,12,19
  327. Integrated Analysis of Whole Genome and Transcriptome Sequencing Reveals Diverse Transcriptomic Aberrations Driven by Somatic Genomic Changes in Liver Cancers, HEPATOLOGY RESEARCH, 44(12), 201411
  328. Integrated Analysis of Whole Genome and Transcriptome Sequencing Reveals Diverse Transcriptomic Aberrations Driven by Somatic Genomic Changes in Liver Cancers, PLOS ONE, 2014
  329. Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey, TRANSPLANT INTERNATIONAL, 2014
  330. Sulindac delayed and suppressed the tumor progression, was not effective on inhibition of tumor initiation in a human colorectal cancer mouse model (CPC;Apc mouse), CANCER RESEARCH
  331. Inflammatory markers as predictors of surgical site infection after elective colorectal surgery: authors' reply
  332. Association of Fc-gamma Receptor Gene Polymorphisms With Susceptibility to Bloodstream Infections After Liver Transplantation, TRANSPLANTATION, 2014
  333. Adoptive Immunotherapy With Deceased Donor Derived-Liver Natural Killer (NK) Cells Is Well Tolerated and Has the Potential to Become a Powerful Therapeutic Tool for Preventing Recurrence of Hepatocellular Carcinoma After Liver Transplantation, TRANSPLANTATION, 2014
  334. Impact of Natural Killer Cell Licensing Associated With KIR-HLA Genotype On the Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy: Can the KIR-HLA Genotype Be a Selection Criterion for Potential Donors for Liver Transplantation With Adoptive Immunotherapy Using NK Cells Extracted From Liver Allografts?, TRANSPLANTATION, 2014
  335. Blockade of CD47-Signaling Regulatory Protein alpha Signaling Enhances the Macrophage Phagocytic Activity Against Cancer Cells, TRANSPLANTATION, 2014
  336. Influence of Adoptive Immunotherapy Employing Allograft Liver-Resident Lymphocytes On Alloimmune Responses., TRANSPLANTATION, 2014
  337. Liver DX5(-) Natural Killer Cells Play a Crucial Role On Instant Blood-Mediated Inflammatory Reaction After Islet Transplantation., TRANSPLANTATION, 201407
  338. The Impact of Toll-Like Receptor Signaling On B Cells Responding to Blood Group A Carbohydrates, TRANSPLANTATION, 201407
  339. Postoperative Portal Hypertension Accelerates Alloimmune Responses in Recipients After Living Donor Liver Transplantation By Impairing Antigen Presenting Capacity of Liver Sinusoidal Endothelial Cells, TRANSPLANTATION, 201407
  340. FOXP3 Gene rs3761548 A Carriers Are Susceptible to Acute Cellular Rejection in Living Donor Liver Transplantation, TRANSPLANTATION, 201407
  341. Novel Adjuvant Immunotherapy Using Liver Natural Killer Cells for Preventing Recurrence of Hepatocellular Carcinoma in Liver Transplantation, LIVER TRANSPLANTATION, 201406
  342. The Impact of Fc gamma Receptor Polymorphism on Infection-Related Complications in ABO-Incompatible Living Donor Liver Transplantation Under Rituximab-Based Immunosuppressive Regimen, LIVER TRANSPLANTATION
  343. Generation of NK Cells from Hematopoietic Stem Cells In Vitro for Anti-HCV and Anti-HCC Immunotherapy: Evaluation Using Human Hepatocyte Chimeric Mice, LIVER TRANSPLANTATION, 201406
  344. Risk Factors of the Hepatocellular Carcinoma Recurrence after Living Donor Liver Transplantation; a Single Center Experience Retrospective Analysis, LIVER TRANSPLANTATION, 201406
  345. Preoperative Prophylaxis With Itraconazole Can Prevent Fungal Infection after Liver Transplantation, LIVER TRANSPLANTATION, 201406
  346. Association of Fc-gamma Receptor Gene Polymorphisms With Susceptibility to Bloodstream Infections After Liver Transplantation, AMERICAN JOURNAL OF TRANSPLANTATION, 201406
  347. Adoptive Immunotherapy With Deceased Donor Derived-Liver Natural Killer (NK) Cells Is Well Tolerated and Has the Potential to Become a Powerful Therapeutic Tool for Preventing Recurrence of Hepatocellular Carcinoma After Liver Transplantation, AMERICAN JOURNAL OF TRANSPLANTATION, 201406
  348. Impact of Natural Killer Cell Licensing Associated With KIR-HLA Genotype On the Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy: Can the KIR-HLA Genotype Be a Selection Criterion for Potential Donors for Liver Transplantation With Adoptive Immunotherapy Using NK Cells Extracted From Liver Allografts?, AMERICAN JOURNAL OF TRANSPLANTATION
  349. Blockade of CD47-Signaling Regulatory Protein alpha Signaling Enhances the Macrophage Phagocytic Activity Against Cancer Cells, AMERICAN JOURNAL OF TRANSPLANTATION
  350. Influence of Adoptive Immunotherapy Employing Allograft Liver-Resident Lymphocytes On Alloimmune Responses, AMERICAN JOURNAL OF TRANSPLANTATION
  351. Liver DX5-Natural Killer Cells Play a Crucial Role On Instant Blood-Mediated Infl ammatory Reaction After Islet Transplantation, AMERICAN JOURNAL OF TRANSPLANTATION
  352. The Impact of Toll-Like Receptor Signaling On B Cells Responding to Blood Group A Carbohydrates, AMERICAN JOURNAL OF TRANSPLANTATION
  353. Postoperative Portal Hypertension Accelerates Alloimmune Responses in Recipients After Living Donor Liver Transplantation By Impairing Antigen Presenting Capacity of Liver Sinusoidal Endothelial Cells, AMERICAN JOURNAL OF TRANSPLANTATION
  354. FOXP3 Gene rs3761548 A Carriers Are Susceptible to Acute Cellular Rejection in Living Donor Liver Transplantation., AMERICAN JOURNAL OF TRANSPLANTATION
  355. Clinical Efficacy of Simultaneous Splenectomy in Liver Transplant Recipients With Hepatitis C Virus, TRANSPLANTATION PROCEEDINGS
  356. Potential Benefit of Mixed Lymphocyte Reaction Assay-based Immune Monitoring After Living Donor Liver Transplantation for Recipients With Autoimmune Hepatitis, TRANSPLANTATION PROCEEDINGS
  357. Bile CXC Motif Chemokine 10 Levels Correlate With Anti-donor Cytotoxic T Cell Responses After Liver Transplantation, TRANSPLANTATION PROCEEDINGS
  358. Risk Factors for Development of New-Onset Diabetes Mellitus and Progressive Impairment of Glucose Metabolism After Living-Donor Liver Transplantation, TRANSPLANTATION PROCEEDINGS
  359. Response: Domino liver transplantation as a valuable option, TRANSPLANT INTERNATIONAL
  360. A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report, WORLD JOURNAL OF SURGICAL ONCOLOGY
  361. Association of Increased Indoleamine 2, 3-Dioxygenase With Impaired Natural Killer Cell Activity in Hemodialysis Patients, THERAPEUTIC APHERESIS AND DIALYSIS
  362. Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG Mice, JOURNAL OF VIROLOGY, 89(19), 10087-10096, OCT 2015
  363. Successful resolution of very severe hepatopulmonary syndrome following adult-to-adult living donor liver transplantation: Report of two cases, HEPATOLOGY RESEARCH, 45(9), 1041-1046, SEP 2015
  364. The modified Glasgow prognostic score for early mortality in patients with synchronous peritoneal carcinomatosis from colorectal cancer, SURGERY TODAY, 45(11), 1396-1403, NOV 2015
  365. Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer, PATHOBIOLOGY, 82(5), 233-241, 2015
  366. Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy, EJSO, 41(11), 1515-1521, NOV 2015
  367. Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient, HEPATOLOGY RESEARCH, 45(10), E150-E155, OCT 2015
  368. Stochastic resonance enhanced tactile feedback in laparoscopic surgery, SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 29(12), 3811-3818, DEC 2015
  369. Prophylactic managements of hepatitis B viral infection in liver transplantation, WORLD JOURNAL OF GASTROENTEROLOGY, 22(1), 165-175, JAN 7 2016
  370. Laparoscopic surgery for colorectal cancer is safe and has survival outcomes similar to those of open surgery in elderly patients with a poor performance status: subanalysis of a large multicenter case-control study in Japan, JOURNAL OF GASTROENTEROLOGY, 51(1), 43-54, JAN 2016
  371. Efficacy and Feasibility of Salvage Living Donor Liver Transplantation after Initial Liver Resection in Patients with Hepatocellular Carcinoma, DIGESTIVE SURGERY, 33(1), 8-14, 2016
  372. An Analysis of Surgical Treatment for the Spontaneous Rupture of Hepatocellular Carcinoma, DIGESTIVE SURGERY, 33(1), 43-50, 2016
  373. Sustained virological response to antiviral therapy improves survival rate in patients with recurrent hepatitis C virus infection after liver transplantation, HEPATOLOGY RESEARCH, 45(11), 1047-1054, NOV 2015
  374. The Role of Liver Sinusoidal Endothelial Cells in Induction of Carbohydrate Reactive B Cells Tolerance Through the Programmed Death 1/Programmed Death Ligand 1 Pathway, TRANSPLANTATION, 99(11), 2325-2336, NOV 2015
  375. Fc-Gamma Receptor Polymorphisms Predispose Patients to Infectious Complications After Liver Transplantation, AMERICAN JOURNAL OF TRANSPLANTATION, 16(2), 625-633, FEB 2016
  376. Long-term outcomes after treatment for T1 colorectal carcinoma, INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 31(3), 571-578, MAR 2016
  377. The Incidence of Posthepatectomy Liver Failure Defined by the International Study Group of Liver Surgery among Living Donors, JOURNAL OF GASTROINTESTINAL SURGERY, 20(4), 757-764, APR 2016
  378. Intraoperative assessment of tissue oxygen saturation of the remnant stomach by near-infrared spectroscopy in two cases of pancreatectomy following gastrectomy, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 22, 75-78, 2016
  379. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer, NATURE GENETICS, 48(5), 500-+, MAY 2016
  380. Inflammatory pseudotumor of the liver occurring during the course of hepatitis C virus-related hepatocellular carcinoma treatment: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 20, 96-100, 2016
  381. Enhanced recovery program is safe and improves postoperative insulin resistance in gastrectomy, WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 8(5), 382-388, MAY 27 2016
  382. h-prune affects anaplastic thyroid cancer invasion and metastasis, ONCOLOGY REPORTS, 35(6), 3445-3452, JUN 2016
  383. Radiopaque biodegradable stent for duct-to-duct biliary reconstruction in pigs, LANGENBECKS ARCHIVES OF SURGERY, 401(4), 513-517, JUN 2016
  384. Effect of Spatial Cognitive Ability on Gain in Robot-Assisted Surgical Skills of Urological Surgeons, JOURNAL OF SURGICAL EDUCATION, 73(4), 624-630, JUL-AUG 2016
  385. Different sensitivity of rituximab-treatment to B-cells between ABO-incompatible kidney and liver transplantation, HUMAN IMMUNOLOGY, 77(6), 456-463, JUN 2016
  386. h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases, INTERNATIONAL JOURNAL OF CANCER, 139(4), 812-823, AUG 15 2016
  387. Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma, CANCER MEDICINE, 5(7), 1546-1555, JUL 2016
  388. Chemotherapeutic outcomes for metastatic colorectal cancer in elderly patients aged >= 75 years: A single-institutional retrospective analysis, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 12(2), 151-158, JUN 2016
  389. Increased Calcineurin A Expression Is Associated with a Lower Relapse-Free Survival Rate after Colorectal Cancer Surgery, PATHOBIOLOGY, 83(6), 308-315, 2016
  390. Three patients treated with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation: Case report, HEPATOLOGY RESEARCH, 46(7), 707-712, JUN 2016
  391. Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation, HEPATOLOGY RESEARCH, 46(7), 622-633, JUN 2016
  392. KRAS mutation leads to decreased expression of regulator of calcineurin 2, resulting in tumor proliferation in colorectal cancer, ONCOGENESIS, 5, AUG 2016
  393. The usefulness of 3-dimensional endoscope systems in endoscopic surgery, SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 30(10), 4562-4568, OCT 2016
  394. Preoperative Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Prediction of Microvascular Invasion in Small Hepatocellular Carcinoma, JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 40(4), 524-530, JUL-AUG 2016
  395. Intrahepatic cholangiocarcinoma coinciding with a liver metastasis from a rectal carcinoma: a case report, SURGICAL CASE REPORTS, 2, SEP 9 2016
  396. Successful treatment of primary advanced gastric plasmacytoma using a combination of surgical resection and chemotherapy with bortezomib: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 27, 133-136, 2016
  397. De novo renal cell carcinoma in a kidney allograft 20 years after transplant, Case Rep Transplant, 679262-679262, 2015
  398. How can we minimize bleeding complications in ABO-incompatible kidney transplant recipients?, Transpl Int., 28(1), 22-24, 2015,01
  399. A case of biliary cystic tumor with repeated hemobilia, Surg Case Rep, 1(1), 34-34, 2015 DEC
  400. Risk Factors for the Development of Desmoid Tumor After Colectomy in Patients with Familial Adenomatous Polyposis: Multicenter Retrospective Cohort Study in Japan, ANNALS OF SURGICAL ONCOLOGY, 23, 559-565, AUG 2016
  401. CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment, PLOS ONE, 11(8), AUG 25 2016
  402. Role of Src Family Kinases in Regulation of Intestinal Epithelial Homeostasis, MOLECULAR AND CELLULAR BIOLOGY, 36(22), 2811-2823, NOV 2016
  403. Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis C: pilot study, JOURNAL OF VIRAL HEPATITIS, 23(11), 850-856, NOV 2016
  404. Laparoscopic extra-abdominal suturing technique for the repair of Larrey's diaphragmatic hernia using the port closure needle (Endo Close (R)): A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 28, 34-37, 2016
  405. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor beta Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation, PLOS ONE, 11(11), NOV 11 2016
  406. Surgical Grasping Forceps With Enhanced Sensorimotor Capability via the Stochastic Resonance Effect, IEEE-ASME TRANSACTIONS ON MECHATRONICS, 21(6), 2624-2634, DEC 2017
  407. Single-incision laparoscopic excision of a chylous mesenteric cyst: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 29, 254-257, 2016
  408. Outcomes of Living Donor Liver Transplantation Alone for Patients on Maintenance Renal Replacement Therapy in Japan: Results of a Nationwide Survey, TRANSPLANTATION DIRECT, 2(6), JUN 2016
  409. A multi-institutional feasibility study of S-1/oxaliplatin plus bevacizumab in patients with advanced/metastatic colorectal cancer: the HiSCO-02 prospective phase II study, SPRINGERPLUS, 5, OCT 18 2016
  410. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients, INTERNATIONAL JOURNAL OF SURGERY, 36, 96-103, DEC 2016
  411. Elective laparoscopic deroofing to treat the spontaneous rupture of a large simple liver cyst: a case report, SURGICAL CASE REPORTS, 2, DEC 7 2016
  412. Simeprevir or telaprevir with peginterferon and ribavirin for recurrent hepatitis C after living-donor liver transplantation: A Japanese multicenter experience, HEPATOLOGY RESEARCH, 46(13), 1285-1293, DEC 2016
  413. Effects of nutritional supplementation with selenium and zinc on natural killer cell activity in hemodialysis patients: a single-arm study, INTERNATIONAL UROLOGY AND NEPHROLOGY, 48(8), 1377-1378, AUG 2016
  414. Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma (vol 41, pg 1860, 2017), WORLD JOURNAL OF SURGERY, 41(7), 1857-1859, 2017
  415. PD-L1/PD-L2-expressing B-1 cells inhibit alloreactive T cells in mice, PLOS ONE, 12(5), 2017
  416. Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma, WORLD JOURNAL OF SURGERY, 41(7), 1860-1870, 2017
  417. PERIOSTIN PROMOTES MALIGNANT POTENTIAL BY INDUCTION OF EPITHELIAL-MESENCHYMAL TRANSITION IN INTRAHEPATIC CHOLANGIOCARCINOMA, GASTROENTEROLOGY, 152(5), S803-S803, 2017
  418. Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: A retrospective cohort study, INTERNATIONAL JOURNAL OF SURGERY, 44, 223-228, 2017
  419. Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer, JOURNAL OF PATHOLOGY, 243(1), 100-110, 2017
  420. Should organs from hepatitis C virus-infected donors be used for transplantation in the era of DAAs?, TRANSPLANT INTERNATIONAL, 30(9), 860-862, 2017
  421. Impact of comorbidities on the postoperative outcomes of acute cholecystitis following early cholecystectomy, SURGERY TODAY, 47(10), 1230-1237, 2017
  422. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver (vol 48, pg 500, 2016), NATURE GENETICS, 48(5), 2016
  423. Effect of Spatial Cognitive Ability on Gain in Robot-Assisted Surgical Skills of Urological Surgeons, JOURNAL OF SURGICAL EDUCATION, 73(4), 624-630, 2016
  424. Impact of human T-cell leukemia virus type 1 on living donor liver transplantation: a multi-center study in Japan, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 23(6), 333-341, 2016
  425. ADOPTIVE IMMUNOTHERAPY WITH ACTIVATED NK CELLS EXTRACTED FROM A LIVER ALLOGRAFT PERFUSATE COMPENSATES FOR THE GENETIC SUSCEPTIBILITY TO BLOODSTREAM INFECTION AFTER LIVER TRANSPLANTATION, TRANSPLANT INTERNATIONAL, 28, 199-199, 2015
  426. BACTERIAL PATHOGENS PROVOKE B CELLS RESPONDING TO BLOOD GROUP A-ANTIGENS TO BE RESISTANT TO CALCINEURIN INHIBITORS THROUGH TLR-MYD88 PATHWAY., TRANSPLANTATION, 99(11), S2-S2, 2015
  427. PROPAGATED NK CELLS FROM HUMAN PLURIPOTENT STEM CELLS EXERT VIGOROUS CYTOTOXICITY AGAINST HCC AND INHIBIT HCV REPLICATION., TRANSPLANTATION, 99(11), S8-S8, 2015
  428. IDENTIFICATION OF A NOVEL TOLEROGENIC B CELL SUBCLASS CO-EXPRESSING BOTH OF PD-L1/PD-L2 TO INHIBIT ALL-REACTIVE T CELLS., TRANSPLANTATION, 99(11), S14-S14, 2015
  429. UP-REGULATION OF ANTI-TUMOR ACTIVITY ON LIVER NK CELLS UNDER THE FASTING CONDITION., TRANSPLANTATION, 99(11), S18-S18, 2015
  430. LIVER-RESIDENT NATURAL KILLER CELLS EXPOSED TO INSTANT BLOOD-MEDIATED INFLAMMATORY REACTION AFTER INTRAPORTAL ISLET TRANSPLANTATION PERSISTENTLY SUSTAIN MEMORY PHENOTYPE WITH CYTOTOXICITY AGAINST ISLETS., TRANSPLANTATION, 99(11), S19-S19, 2015
  431. A Novel Approach for Preventing HCC Recurrence after LT: Adoptive Immunotherapy Using Donor Liver Natural Killer Cells To Prevent Hepatocellular Carcinoma Recurrence after Liver Transplantation, TRANSPLANTATION, 99, 111-111, 2015
  432. Gene expression profiling for oncogenic Kras mutation in mice and human colorectal cancer, CANCER RESEARCH, 75, 2015
  433. The generation of colorectal cancer mouse model based on microsatellite instability and the identification of transforming growth factor-beta signal target, CANCER RESEARCH, 75, 2015
  434. Impact of synbiotics administration on tumorigenesis of colon cancer mouse model, CANCER RESEARCH, 75, 2015
  435. Whole genome sequencing analysis of multiple liver cancer nodules for determination of causal events for multi-occurrence, CANCER RESEARCH, 75, 2015
  436. Central bisectionectomy for hepatocellular carcinoma in a patient with indocyanine green excretory defect associated with reduced expression of the liver transporter, Surg Case Rep, 2(1), 89-89, 201612
  437. Assessment of cancer pain in a patient with communication difficulties: a case report, J Med Case Rep, 10(1), 148, 20160602

Publications such as books

  1. 2015, Surveillance of de novo malignancy after living-donor liver transplantation, 2015

Invited Lecture, Oral Presentation, Poster Presentation

  1. Adjuvant immunotherapy using liver NKCells enhances protective immunity against HCC recurrence and infectious complications in live rtransplantation., 2014/04/03, With Invitation
  2. Controlling Anti-Carbohydrate Antibody Responses in Xenotransplantation, WTC2014, 2014/07/26, Without Invitation
  3. Impact of Fc-gamma receptor gene polymorphisms on susceptibility to infectious complication after liver transplantation, Japan Korea Transplantation Forum 2014, 2014/09/12, Without Invitation
  4. Immunological feature of liver transplant recipients infected with HBV, 2014/11/20, Without Invitation
  5. Hepatocellular carcinoma patients who radiologically meet but pathologically exceed the Milan criteria are susceptible to recurrence after living-donor liver transplantation, Hideki Ohdan, 2015/06/11, With Invitation, tokyo
  6. New approaches for ABO-mismatched solid organ transplantation., Hideki Ohdan, The 25th Regional Congress of the ISBT 2015, 2015/06/29, With Invitation, ISBT, LONDON
  7. The depletion of liver natural killer cells lead to successful engraftment of intraportal transplanted islet when insufficient number of islets used for islet transplantation, Saeki Y,Ishiyama K, Ishida N, Tanaka Y, Ohdan H., 2016/04, Without Invitation
  8. Distinct sensitivity of B-1a/B-1b/B-2 cell subpopulations to immunosuppressants, Ohdan H., Transplantation Science Symposium Asian Regional Meeting 2016, 2016/04, Without Invitation
  9. The depletion of liver natural killer cells lead to successful engraftment of intraportal transplanted islet when insufficient number of islets used for islet transplantation, Saeki Y,Ishiyama K, Ishida N, Tanaka Y, Ohdan H., Transplantation Science Symposium Asian Regional Meeting 2016, 2016/04, Without Invitation
  10. The Alcohol Use Disorder Identification Test-Consumption (AUDIT-C) predicts the risk of excessive alcohol consumption in patients after liver transplantation, Yano T, Ohira M, Sakamoto R, Narisada A, Tahara H, Ide K, Ishiyama K, Ohdan H., Transplantation Science Symposium Asian Regional Meeting 2016, 2016/04, Without Invitation
  11. The phenotypic and functional distinction between B cells with receptors for human blood group A and B antigens, Sakai H,Tanaka Y, Masahiro Y, Ohdan H., Transplantation Science Symposium Asian Regional Meeting 2016, 2016/04, Without Invitation
  12. Assessment using a novel predictive value and treatment for steroid-resistant acute cellular rejection after liver transplantation, Tahara H,Ishiyama K, Ide K, Tanaka Y, Ohira M, Tanimine N, Shimizu S, Kobayashi T, Ohdan H, Transplantation Science Symposium Asian Regional Meeting 2016, 2016/04, Without Invitation
  13. 術中内視鏡を併用し根治切除しえた十二指腸腺腫・粘膜内癌の4例, 山本悠司,田邊和照, 堀田龍一, 佐伯吉弘, 竹原寛樹 大段秀樹., 第118回広島消化器病研究会, 2016/04, Without Invitation
  14. 消化器外科手術後における静脈血栓塞栓症の発症予測マーカーとしての可溶性フィブリンモノマー複合体(Soluble fibrin monomer complex,SFMC)の意義, 河内雅年,下村学, 檜井孝夫, 田邊和照, 惠木浩之, 石崎康代, 安達智洋, 田代裕尊, 大段秀樹., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation
  15. 肝移植術後重症感染症の起因菌推測と抗生剤選択における自然免疫遺伝子多型の意義, 清水誠一,田中友加, 石山宏平, 井手健太郎, 大平真裕, 田原裕之, 谷峰直樹, 佐伯吉弘, 坂井寛, 矢野琢也, 小林剛, 大段秀樹., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation
  16. 80 歳以上の高齢者根治切除施行大腸がん手術症例におけるBMI による解析, 安達智洋,檜井孝夫, 川口康夫, 大段秀樹, 金澤旭宣, 中西正芳, 久保義郎, 伊藤雅昭, 猪俣雅史, 伴登宏行, 八岡利昌, 植木隆, 渡邊昌彦., 第116回日本外科学会定期学術集会, Without Invitation
  17. 80 歳以上の高齢者根治切除施行大腸がん手術症例におけるBMI による解析, 安達智洋,檜井孝夫, 川口康夫, 大段秀樹, 金澤旭宣, 中西正芳, 久保義郎, 伊藤雅昭, 猪俣雅史, 伴登宏行, 八岡利昌, 植木隆, 渡邊昌彦., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation
  18. 大腸癌肝転移切除症例におけるGlasgow Prognostic Score の意義, 沖本将,小林剛, 田代裕尊, 石山宏平, 井手健太郎, 大平真裕, 田原裕之, 黒田慎太郎, 谷峰直樹, 岩子寛, 橋本昌和, 濱岡道則, 惠木浩之, 大段秀樹., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation
  19. 肝細胞癌切除後の肝外再発予測因子, 橋本昌和,小林剛, 田代裕尊, 石山宏平, 井手健太郎, 大平真裕, 田原裕之, 黒田慎太郎, 岩子寛, 濱岡道則, 沖本将, 大段秀樹., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation
  20. 細菌感染症により誘発される難治性抗体関連拒絶反応の新規メカニズムの解明, 坂井寛,田中友加, 山下正博, 佐々木由布, 中野亮介, 田口和浩, 石田伸樹, 柳川泉一郎, 矢野琢也, 佐伯吉弘, 清水誠一, 谷峰直樹, 大平真裕, 田原裕之, 井手健太郎, 石山宏平, 尾上隆司, 田代裕尊, 大段秀樹., 第116回日本外科学会定期学術集会, 2016/04, Without Invitation
  21. Significant association of Vitamin-D Receptor (VDR) Gene Polymorphism and Incidence od De Novo DSA in Renal Transplantation, Das Lalit Kumar,Ide K, Tanaka Y, Tanimine N, Verma S, Ohdan H., American Transplant Congress 2016, 2016/06, Without Invitation
  22. Significant association of Innate Immune Related Genes Polymorphism on Infectious Complications Following Early Post Renal Transplantation Phase., Das Lalit Kumar,K.Ide, Y.Tanaka, S.Shimizu, N.Tanimine, S.Verma, H.Ohdan, American Transplant Congress 2016, 2016/06, Without Invitation
  23. Impact of Immunosuppressants on Inducing Regulatory T Cells in Human Allo-Immune Responses., Tanaka Y,Ohdan H., American Transplant Congress 2016, 2016/06, Without Invitation
  24. Cross-Talk Between TLR and BCR Pathways Induces CNI-Resistance in B-Cells Responding to Blood Group A-Antigens: A Novel Paradigm for Treatment with TLR-Inhibitor for CNI-Resistant AMR., Sakai H,Tanaka Y, Ohdan H., American Transplant Congress 2016, 2016/06, Without Invitation
  25. Immunotherapy using donor liver NK cells for preventing severe infection after liver transplantation, 2016/07, Without Invitation
  26. Liver DX5- memory natural killer cells sustain cytotoxicity against intraportally transplanted islet, 2016/07, Without Invitation
  27. Cotransplantation of preactivated mesenchymal stem cells inhibits liver natural killer cell–induced islet graft injury during instant blood-mediated inflammatory reaction after syngeneic intraportal islet transplantation, Ishida N,Ohdan H, Ishiyama K, Saeki Y, Tanaka Y, Tahara H, Verma S, Saparbay D, Sasaki Y, Onoe T, Ohira M, Yano T, Yanagawa S, Taguchi K, Piao J, Tanaka A, Ide K, Shimizu S, Das L K, Nakano R., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  28. Negative influence of liver irradiation on liver resident NK cells., Nakano R,Ohira M, Yano T, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  29. Long-lasting expansion of memory-like natural killer cells in the liver after intraportal syngeneic islet transplantation in mice, Saeki Y,Ishiyama K, Ishida N, Tanaka Y, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  30. Various pathogenic microbes induce CNI-resistance in B-cells responding to blood group antigens through TLR-MyD88 pathway, Sakai H,Tanaka Y, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  31. Clinical and immunological significance of controlling portal vein pressure in living donor liver transplantation, Taguchi K,Onoe T, Hashimoto S, Tanaka Y, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  32. Different sensitivity of rituximab-treatment to B-cells between ABO-incompatible kidney and liver transplantation., Tanaka A ,Morimoto H, IdeK, Tanaka Y, Ishiyama K, Ohira M, Tahara H, Shimizu S, Saeki Y, Sakai H, Tano T, Ishida N, Yanagawa S, Tagushi K, Nakano R, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  33. Human endothelial-like cells transdifferentiated from monocytes suppress allo-reactive T cells, Tanaka Y,Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  34. Development of an anti-HLA antibody-producing humanized mouse model, Yanagawa S,Tahara H, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  35. Reduction in CXCL9–CXCR3 signals diminishes TRAIL-expressing liver NK cells in partially hepatectomized mice under depressed immune status., Yano T、Ohira M, Nakano R, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation
  36. 生体肝移植後にニューモシスチス・カリニ肺炎を発症しveno-venous Extra corporeal membrane oxygenation(vv-ECMO)にて救命し得た1例, 秋本修志 、田原裕之, 高橋元, 中島一記, 田口和浩, 田中飛鳥, 中野亮介, 石田伸樹, 柳川泉一郎, 矢野琢也, 坂井寛, 佐伯吉弘, 清水誠一, 大平真裕, 井手健太郎, 石山宏平, 黒田慎太郎, 小林剛, 大段秀樹., 2016/08, Without Invitation
  37. von Willebrand病患者において安全に肝切除術を施行し得た1例, 2016/09, Without Invitation
  38. 切除不能進行胃癌に対するConversion Surgeryの可能性 -胃癌肝転移に対する肝切除の適応基準の確立を目指して-, 堀田龍一、田邊和照, 鈴木崇久, 三隅俊博, 佐伯吉弘, 山本悠司, 竹原寛樹, 柳川泉一郎, 高橋元, 大段秀樹., 第91回中国四国外科学会総会, 2016/09, Without Invitation
  39. 持続性ウイルス学的著効後に発症したC型肝炎関連肝細胞癌に対する肝切除後再発予測因子の検討, 沖本将、小林剛, 黒田慎太郎, 石山宏平, 井手健太郎, 大平真裕, 田原裕之, 清水誠一, 岩子寛, 濱岡道則, 本明慈彦, 山口恵美, 大段秀樹., 第91回中国四国外科学会総会, 2016/09, Without Invitation
  40. 局所進行直腸癌に対する術前化学放射線療法(CRT)の検討, 寿美裕介、惠木浩之、佐田春樹、安達智洋、向井正一郎、河内雅年、矢野琢也、田口和浩、中島一記、大段秀樹, 第91回中国四国外科学会総会, 2016/09, Without Invitation
  41. 同時性大腸癌腹膜播種症例における術前mGPSによる治療選択の検討, 田口和浩 安達智洋、惠木浩之、向井正一朗、矢野琢也、河内雅年、佐田春樹、寿美裕介、中島一記、田邊和昭、大段秀樹, 第110回広島がん治療研究会, 2016/09, Without Invitation
  42. 肝細胞癌に対する治癒切除症例の肝外再発予測因子, 本明慈彦 小林剛、橋本昌和、黒田慎太郎、石山宏平、井手健太郎、大平真裕、田原裕之、岩子寛、濱岡道則、沖本将、山口恵美、大段秀樹, 第110回広島がん治療研究会, 2016/09, Without Invitation
  43. ABO血液型不適合移植における脱感作療法(腎移植・肝移植), 2016/09, With Invitation
  44. 臓器移植におけるATGの役割, 大段秀樹, 第52回日本移植学会総会, 2016/09, With Invitation
  45. 清水誠一 田中友加, 大平真裕, 石山宏平, 井手健太郎, 田原裕之, 佐伯吉弘, 坂井寛, 矢野琢也, 小林剛, 大段秀樹., 2016/09, Without Invitation
  46. 広島大学における急性肝不全症例に対する肝移植の検討, 2016/09, Without Invitation
  47. Toll-like receptor阻害剤を用いた新たな血液型抗原応答B細胞特異的制御法の基礎的解析, 2016/09, Without Invitation
  48. Expression of Signal peptidase complex 18 is associated with poor survival of patients with esophageal cancer, yuji yamamoto Naohide Oue, Takeharu Imai, Naoya Sakamoto, Kazuhiro Sentani, Hideki Ohdan, Wataru Yasui, 2016/10, Without Invitation
  49. Biomarker analysis to predict the pathological response of locally advanced gastric cancer to neoadjuvant chemotherapy: An exploratory study of the randomized phase II COMPASS tria, Tanabe K Yoshikawa T, Oshima Y, Miyagi S, Morita K, Nishikawa Y, Ito T, Matsui Y, Kimura T, Aoyama T, Hayashi T, Ogata H, Cho A, Tuburaya J, Sakamoto, ESMO 2016, 2016/10, Without Invitation
  50. Japanese experience 1, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, With Invitation
  51. How to organize and support basic and translational research in transplantation, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, With Invitation
  52. Players of clinical tolerance: Tregs, Bregs, Macrophages, and others, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, With Invitation
  53. Comparison of anti-donor immune response in recipients after kidney and pancreas-kidney transplantation, Kohei Ishiyama,Nobuki Ishida, Kentaro Ide, Yuka Tanaka, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, Without Invitation
  54. The Significant Association Between FOXP3 Gene Polymorphism and Severity of Acute Cellular Rejection in Liver Transplantation., Yuka Tanaka,Sapana Verma, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, Without Invitation
  55. Corticosteroids dampen Natural Killer cell function including cytotoxicity and anti-HCV effect, Masahiro Ohira,Ryuichi Hotta, Takuya Yano, Ryosuke Nakano, Andreas Tzakis, Seigo Nishida, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10, Without Invitation
  56. Current status of desensitization protocol for highly HLA-sensitized kidney transplant candidates, Kentaro Ide Hiroyuki Tahara, Asuka Tanaka, Shuji Akimoto, Sapana Verma, Lalit Kumar Das, Seiichi Shimizu, Masahiro Ohira, Kohei Ishiyama, Yuka Tanaka, Hideki Ohdan, 第50回日本臨床腎移植学会, 2017/02, Without Invitation
  57. Neo-adjuvant chemotherapy with G-SOX therapy for locally advanced gastric cancer., 89th Annual Meeting of the Japanese Gastric Cancer Association, 2017/03, Without Invitation
  58. The future perspective of conversion surgery for gastric cancer with liver metastasis, 89th Annual Meeting of The Japanese Gastric Cancer Association, 2017/03, Without Invitation
  59. IQGAP3 is involved in spheroid formation of gastric cancer cells, Yuji Yamamoto, Naohide Oue, Takeharu Imai, Kazuaki Tanabe, Hideki Ohdan, Naoya Sakamoto, Kazuhiro Sentani, Kazuhiro Yoshida, Wataru Yasui, 第89回日本胃癌学会, 2017/03, Without Invitation
  60. Overexpression of PCDHB9 is associated with poor prognosis in gastric cancer, 2016/10, Without Invitation
  61. IQGAP3 is involved in spheroid formation of gastric cancer cells, 89th Annual Meeting of the Japanese Gastric Cancer Association, 2017/03, Without Invitation
  62. Transmembrane protein BST2 is associated with poor survival in patients with gastric cancer, 89th Annual Meeting of the Japanese Gastric Cancer Association, 2017/03, Without Invitation
  63. Overexpression of KIFC1 is associated with gastric spheroid formation, 89th Annual Meeting of the Japanese Gastric Cancer Association, 2017/03, Without Invitation

Awards

  1. 2010年10月, CHUGAI Award, ドナー肝由来リンパ球を用いた肝移植後肝癌・C型肝炎再発予防免疫療法の臨床評価
  2. 2011年06月11日, International TTS-JST Basic Science Mentee/Mentor Travel Award, XII The Transplantation Society Basic Science Symposium Chair Anita Chong, MD
  3. 2015年11月17日, DP(Distinguished Professor), Hiroshima University
  4. 2015年12月07日, Honorable Mention International Conference on Advanced Mechatronics (ICAM) 2015, ICAM2015 General Chair

External Funds

Acceptance Results of Competitive Funds

  1. Health and Labour Sciences Research Grants, 2013/04/01, 2014/03/31
  2. KAKENHI, Establishment of strategies to regulate antibody-mediated rejection on the basis of B cell differentiation biology, 2011, 2012
  3. KAKENHI, The CD47-SIRPa signaling blockade accelerates macrophage phagocytic activity against cancer cells, 2011, 2013
  4. KAKENHI, The new strategy of NK cell therapy with death receptors for the patients with chollangiocellular carcinoma or mixed liver cancer, 2010, 2012
  5. KAKENHI, 2009, 2010
  6. KAKENHI, Inhibition of xeno-antigen reactive T cells and B cells by regulation of CD47-SIRP signaling, 2008, 2010
  7. KAKENHI, GalT-knockout pig to monkey xenogeneic kidney and islet transplantation, 2007, 2010
  8. KAKENHI, 2007, 2008
  9. KAKENHI, Regulation of innate and adaptive immune responses in xenotransplantation by modulating CD47sirp alpha signaling, 2006, 2007
  10. KAKENHI, Elucidation of the mechanism on carbohydrate antigen recognition by B cells through CD1d mediated signaling and establishment of a method to regulate B cells responding to the carbohydrate antigens in ABO-incompatible transplantation and xe, 2006, 2007
  11. KAKENHI, 2006, 2007
  12. KAKENHI, 2005, 2006
  13. KAKENHI, 2005, 2006
  14. KAKENHI, 2005, 2006
  15. KAKENHI, Elucidation of mechanisms for macrophage-mediated xenograft refection and a novel approach to prevent macrophage-mediated xenograft rejection by gene introduction of human CD47 to xenogenic cells, 2004, 2005
  16. KAKENHI, Development of synthetic immunotoxin that can enable ABC incompatible transplantation and xenotransplantation., 2004, 2005
  17. KAKENHI, 2015, 2016
  18. KAKENHI, 2015, 2017
  19. KAKENHI, 2015, 2018
  20. 2014/03/01, 2017/03/31

Social Activities

History as Peer Reviews of Academic Papers

  1. 2010, Surgery Today
  2. 2011, Surgery Today
  3. 2012, Surgery Today
  4. 2012, Hepatology Research
  5. 2013, Surgery Today
  6. 2013, Hepatology Research
  7. 2014, Surgery Today
  8. 2014, Hepatology Research
  9. 2014, Transplant International, Associate Editor, 24
  10. 2014, Surgical case reports, Associate Editor, 24
  11. 2015, Hepatrology Research, associate editor
  12. 2015, Surgical case reports, associate editor
  13. 2015, Transplant International, associate editor
  14. 2016, Hiroshima Journal of Medical Science, 0
  15. 2016, Transplant International, associate editor
  16. 2016, Surgical case reports, associate editor
  17. 2016, Hepatology Research, associate editor